HomeLRMR • NASDAQ
add
Larimar Therapeutics Inc
Previous close
$1.81
Day range
$1.82 - $1.90
Year range
$1.61 - $11.20
Market cap
119.73M USD
Avg Volume
927.34K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
14 hours ago
S&P 500 tallies its first ‘death cross’ in 3 years. Here’s what happens next.
0.79%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 31.29M | 120.96% |
Net income | -28.82M | -121.84% |
Net profit margin | — | — |
Earnings per share | -0.45 | -55.17% |
EBITDA | -31.22M | -121.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 183.45M | 111.38% |
Total assets | 200.22M | 108.71% |
Total liabilities | 28.41M | 99.88% |
Total equity | 171.81M | — |
Shares outstanding | 64.03M | — |
Price to book | 0.67 | — |
Return on assets | -37.32% | — |
Return on capital | -41.10% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -28.82M | -121.84% |
Cash from operations | -21.82M | -133.49% |
Cash from investing | 19.20M | 830.20% |
Cash from financing | 36.00K | — |
Net change in cash | -2.58M | 78.43% |
Free cash flow | -11.51M | -145.39% |
About
Founded
2005
Headquarters
Website
Employees
65
